LMG Life Sciences notes Jorge “is a fixture in the patent prosecution world and builder of the firm’s biotech practice.” A peer in the report remarks, “Jorge Goldstein is one of the best patent lawyers in the country. I’ve called him before on thorny issues, and he’s great.”
Overview
Jorge A. Goldstein, Ph.D. is a founder of the firm and a director in Sterne Kessler’s Biotechnology & Chemical Practice Group. He is considered by his peers and clients to be one of the country’s pioneers in biotechnology patent law. Among his many awards, in 2017, Jorge was inducted into LMG Life Sciences Hall of Fame. He wrote the book U.S. Biotechnology Patent Law, first published in 2016, with an eighth, updated edition published in 2023. The book guides readers in understanding case law dealing with patents in biotechnology. His new book, Patenting Life, which is a history of biotechnology told through his own and others’ intellectual property cases, will be published in late 2024 by Georgetown University Press.
He has forty-six years’ experience in the preparation and prosecution of patent applications before the U.S. and foreign patent offices in scientific areas such as genomics, molecular and cell biology, recombinant DNA technology, immunology, transgenics, therapeutic methods, stem cells, pharmaceuticals and BioFETs (biological field effect transistors).
He has handled several and varied interferences over many years, including successful appeals to the Court of Appeals for the Federal Circuit. He has also been involved in inter partes reviews at the USPTO, as well as European oppositions, arbitrations in District Court, and in Appellate litigation both as counsel and expert witness. He is a multiply-accredited Certified Licensing Professional. As such, he has counseled clients on intellectual property strategy, trade secrets, licensing, research contracts, university-industry relations, federal licensing, due diligence, acquisitions, and employment agreements. He was lead counsel in the 1988 appellate case of In re Wands et al. 8 USPQ2d 1400 (Fed. Cir.), a pivotal decision on biotechnology enablement requirements. In addition, Jorge founded the firm’s IP and Human Rights Pro Bono Practice, which was recognized as the winner of the 2015 Financial Times’ Most Innovative North American Lawyers award in the “Innovation in a Social Responsibility Project” category.
Between 2012 and 2016, Jorge was Visiting Professor of Law at the Universidad Austral in Buenos Aires, Argentina, where he taught biotech patent law in the then only WIPO-certified regional master’s IP program in Latin America.
Jorge received his J.D. from The George Washington University Law School with high honors, and his Ph.D. in chemistry from Harvard University. He earned his B.S. in chemistry from Rensselaer Polytechnic Institute.
Education
- J.D., The George Washington University Law School, with high honors
- Ph.D., Chemistry, Harvard University
- B.S., Chemistry, Rensselaer Polytechnic Institute
Languages Spoken
- Spanish
- French
- German